Tannins

Tannins: A Comprehensive Reference

1. Identity, Classification, and Chemical Nature

Tannins are a broad class of polyphenol compounds of high molecular weight (500–3,000 Daltons) ubiquitously present in commonly consumed plant foods, and are responsible for the astringent taste of many fruits and beverages. Tannins are a heterogeneous group of polyphenols — secondary metabolites in plants synthesized in response to biotic and abiotic stress inducers. The term "tannin" is not a single chemical entity but rather an umbrella designation for a structurally diverse family of plant polyphenols united by their ability to bind and precipitate proteins.

Tannins have been extensively used since the 18th century by leather manufacturers to improve leather resistance in the dyeing or tanning process, as they can precipitate gelatin adhered to animal skin and provide a brownish color — hence the name of this group of phytochemicals.

1.1 Major Classes

Tannins are classified into hydrolyzable tannins, condensed tannins, complex tannins, and pseudo-tannins.

Hydrolyzable Tannins (HTs): Hydrolyzable tannins consist of a polyol core, often glucose, esterified with phenolic acids like gallic or ellagic acid. Hydrolyzable tannins are esters formed from glucose or other polyols and ellagic acid (ellagitannins) or gallic acid (gallotannins). The principal HT subclasses are therefore the gallotannins (e.g., tannic acid, pentagalloylglucose) and the ellagitannins (e.g., punicalagins, punicalins, castalagin). Tannic acid is the simplest hydrolyzable tannin and is approved as a weakly acidic food additive by the US Food and Drug Administration (FDA). It has attracted attention due to its extensive physiological activities, which include antioxidant, antitumoral, antimicrobial, and anti-inflammatory actions, as well as its ability to interact with proteins. Tannic acid is composed of a core glucose molecule connected to 10 galloyl groups by aliphatic ester bonds.

Condensed Tannins (CTs) / Proanthocyanidins: Condensed tannins are polymers of flavan-3-ols, flavan-4-diols, or related flavanol residues linked via carbon–carbon bonds. Chemically, they are oligomeric flavonoids. Many are oligomers of catechin and epicatechin and their gallic acid esters. The most common B-type dimers, B1, B2, B3, and B4, are associated with C4–C8 chemical bonds, while B5, B6, B7, and B8 contain C4–C6 interflavan bonds. In contrast, A-type proanthocyanidins have double bonds involving the C2 and C4 carbons of the upper unit and oxygen bonds at the C7 and C6 or C8 positions. This A-type linkage, present in cranberry and peanut skin proanthocyanidins, confers distinct biological properties including anti-adhesion activity.

Complex Tannins: Complex tannins encompass the basic unit of flavones formed by the combination of either an ellagitannin or a gallotannin unit with catechin through glycosidic bonds or ester linkages. They represent a hybrid structure, combining the properties of both main tannin classes, resulting in distinct chemical and biological characteristics. Although not as widely studied as hydrolyzable or condensed tannins, complex tannins are found in various plant species.

1.2 Key Individual Compounds

• Punicalagins — the predominant ellagitannins in pomegranate (Punica granatum), comprising the major source of pomegranate antioxidant activity.
• Pentagalloylglucose (PGG) — a gallotannin with demonstrated antimicrobial, anti-inflammatory, antidiabetic, and antioxidant properties. Penta-O-galloyl-β-D-glucose has raised considerable interest because of its valuable functional properties and potential application as an antimicrobial, anti-inflammatory, antidiabetic, and antioxidant agent.
• Procyanidin B1 and B2 — condensed tannin dimers found in grape seed and cocoa. Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract.
• Ellagic acid — a hydrolysis product of ellagitannins with independent bioactivity; subsequently converted to urolithins by gut microbiota.
• Tannic acid — the prototypical hydrolyzable tannin used in food, pharmaceutical, and industrial applications.

2. Natural Sources and Distribution

Tannins are natural phenolic compounds that are widespread and almost ubiquitous in the vegetal world. They can be found in fruit, wood, and bark of trees, and in many types of wild herbs and plants or from sustainable agriculture and forestry.

Nearly half of all plant-derived foods serve as dietary sources of proanthocyanidins. Major botanical sources include:

• Fruits: Pomegranate (Punica granatum, pericarp and juice), grapes (Vitis vinifera, seeds and skin), cranberries (Vaccinium macrocarpon), blueberries, raspberries, strawberries, blackberries, persimmons, and mangoes.
• Nuts: Walnuts, chestnuts, and peanut skins are significant sources of condensed and hydrolyzable tannins.
• Bark and Wood: Oak (Quercus spp.), willows (Salix spp.), quebracho (Schinopsis balansae), sumac (Rhus spp.), maples (Acer spp.), wattle (Acacia spp.), eucalyptus (Eucalyptus spp.), and red mangrove (Rhizophora spp.).
• Legumes and Cereals: Sorghum, fava beans, lentils, and chickpeas are notable sources, particularly of condensed tannins.
• Beverages: Tea (Camellia sinensis, both green and black), red wine, and certain fruit juices are major dietary vehicles for tannin intake.
• Medicinal Plants: Witch hazel (Hamamelis virginiana), bearberry (Arctostaphylos uva-ursi), and wattle (Acacia mearnsii) are pharmaceutically important sources.

Among Acacia nilotica, the highest tannin levels are located in their fruits (22%), while leaves and bark account for half of this quantity. Ellagitannins can occur in different plant foods, including pomegranates, berries (strawberries, raspberries, blackberries, etc.), walnuts, many tropical fruits, medicinal plants, and herbal teas, including green and black Camellia sinensis teas.

3. Common Forms and Preparations

Tannins are available and studied in a range of forms:

• Crude botanical extracts — standardized liquid or powdered extracts from grape seed, pomegranate peel/juice, pine bark (Pinus pinaster, marketed as Pycnogenol®), witch hazel bark, or chestnut. Commercially available pomegranate extract dietary supplements are found in the form of capsules, tablets, and soft gels.
• Grape seed extract (GSE) — standardized to a high concentration of proanthocyanidins; the composition of GSE has been described to consist of more than 95% flavanols, of which 86% were proanthocyanidins.
• Pomegranate juice concentrate and standardized extracts — standardized variously to punicalagins or ellagic acid. The content of ellagic acid has been used to standardize most pomegranate extract dietary supplements marketed. However, supplements can be adulterated with ellagic acid from less expensive plant sources, undercutting this method of standardization.
• Tannic acid (pharmaceutical grade) — used topically and as a food additive; recognized by the FDA.
• Tannin-rich herbal preparations — decoctions, infusions, tinctures, and dried plant material used in traditional and phytopharmaceutical contexts.
• Wattle tannin (Acacia mearnsii) extract — the tannin fraction of A. mearnsii is commercially available as a food supplement after hot water extraction.

4. Traditional and Historical Use

Tannins have been used throughout history for their pharmacological properties as part of plants and herbs in traditional medicine. They are polyphenolic compounds historically utilized in textile and adhesive industries, but also in traditional human and animal medicines or foodstuffs.

Tanning is an ancient technique estimated to have occurred as long ago as 5,000 B.C. in Egypt. Ancient Greeks and Romans are known to have used oak to tan animal skins into leather. In China, tanning occurred many thousands of years ago.

Historically, tannin-containing plants have been used by both Western and Eastern cultures as traditional medicine for various disorders, in particular as an antiphlogistic for inflammatory conditions.

Their traditional use for leather has been doubled for centuries in the popular medical and pharmacological lore by their use to cure or alleviate a variety of infections and diseases. Specific historical uses documented across traditions include:

• Wound healing and hemostasis: Astringent bark preparations from oak, witch hazel, and sumac were applied topically across European, North American indigenous, and Asian traditional medicine systems to arrest bleeding, tighten skin, and treat burns and skin disorders. The protein-precipitating action of tannins formed a physical barrier over wounds.
• Gastrointestinal disorders: Tannin-rich preparations — particularly decoctions of oak bark, pomegranate peel, and sorghum grain — were used across Africa, Asia, and Europe to treat diarrhea and dysentery, a use rooted in their protein-binding and astringent properties. The presence of tannins may contribute to a plant's astringent and antidiarrheal properties.
• Oral health: Chewing of tannin-rich bark and plant material was practiced in multiple traditional African and Asian cultures to protect teeth and gums against infection.
• Inflammation: Topical and oral use of tannin-rich plants for inflammatory conditions — including joint pain, sore throat, and skin inflammations — is recorded in European and Ayurvedic traditions.
• Acacia nilotica (Vachellia nilotica) — widely documented for its traditional uses in African and Middle Eastern medicine, including for wound healing, gastrointestinal complaints, and antimicrobial applications.
• Pomegranate (Punica granatum) — the peel has been used in Ayurvedic, Unani, and traditional Chinese medicine for diarrhea, intestinal parasites, and inflammatory conditions for thousands of years.
• Witch hazel (Hamamelis virginiana) — used by Indigenous North American peoples and subsequently integrated into European pharmacopoeia as an astringent, for hemorrhoids, and for skin inflammation.

The revision of traditional knowledge paired with scientific evidence may provide a supporting background on the use of tannins and the basis for developing innovative pharmacology and food applications based on formulations using natural sources of tannins.

5. Key Constituents and Mechanisms of Action

5.1 Protein Binding and Astringency

The most fundamental chemical property of tannins — and the basis for many of their biological activities — is their capacity to bind proteins. Tannins are multidentate ligands which may bind to proteins, mainly by hydrophobic interactions and hydrogen bonds. The strength of tannin–protein binding is related to tannin's molecular weight; that is, the larger number of binding sites improves binding. This protein-precipitating property is responsible for the astringent sensation in the mouth and underlies their antimicrobial, antidiarrheal, and wound-healing effects.

5.2 Antioxidant Activity

Condensed tannins, particularly proanthocyanidins, consistently display potent antioxidant activity through radical scavenging, metal chelation, and activation of endogenous defenses, thereby underpinning their anti-inflammatory, anti-ischemic, neuroprotective, and metabolic actions. Hydrolyzable tannins similarly exert strong antioxidative effects that support antimicrobial activity, enzyme modulation, and protection against neuroinflammation.

5.3 Antimicrobial Mechanisms

The mechanisms proposed to explain tannin antimicrobial activity include inhibition of extracellular microbial enzymes, deprivation of the substrates required for microbial growth, direct action on microbial metabolism through inhibition of oxidative phosphorylation, metal ion deprivation, or formation of complexes with the cell membrane of bacteria causing morphological changes of the cell wall and increasing membrane permeability. Although protein precipitation is a universal property for all tannins, antimicrobial activity of tannins is microbial species-specific and is closely related to the chemical composition and structure of tannins.

Some plant polyphenols, especially tannins, directly inhibit bacteria by denaturation of bacterial proteins. As this is a physical effect, it is highly unlikely that the bacteria develop any resistance to tannins.

5.4 Anti-Inflammatory Mechanisms

Tannins possess varying anti-inflammatory activities that are positively associated with their antioxidant activities. The anti-inflammatory properties of tannins from different sources may be caused by regulating cytokine expression, reducing the production of inflammatory substances, and enhancing complexation with other molecules. Tannins can form a gastroprotective barrier to improve gastritis symptoms based on their antioxidant activity.

5.5 Enzyme Inhibition

Naturally occurring polyphenols, e.g., condensed tannins, can inhibit a number of digestive enzymes, including α-amylase, α-glycosidase, pepsin, trypsin, lipase, and chymotrypsin. Inhibition of α-amylase and α-glucosidase is one proposed mechanism underlying the antidiabetic and hypoglycemic properties of tannins, as these enzymes are responsible for carbohydrate digestion and glucose release.

5.6 Antiviral Activity

Some papers have reported that tannins have the ability to prevent viral infection such as HIV, bovine adeno-associated virus (BAAV), and norovirus. Tannic acid was identified as a strong inhibitor in the binding of norovirus to HBGA receptors in a saliva-based binding/blocking assay.

5.7 Cardiovascular Mechanisms

Proanthocyanidin-related cardiovascular effects include vasodilation, presumably as a result of increased nitric oxide production, decreased platelet aggregation, reduced sensitivity of low-density lipoproteins (LDL) to oxidization, and modulation of several reactions associated with inflammation.

5.8 Bioavailability and Gut Microbiota Metabolism

Tannins exert their biological effects in two ways: (1) as unabsorbed complex structures acting in the gastrointestinal tract with antioxidant, antimicrobial, and antinutritional properties; or (2) as low-molecular-weight tannins and microbial metabolites exerting systemic effects in various organs.

The bioavailability of ellagitannins and ellagic acid is very low. These molecules suffer extensive metabolism by the gut microbiota to produce urolithins that are much better absorbed. Urolithins circulate in plasma as glucuronide and sulfate conjugates at concentrations in the range of 0.2–20 μM.

In contrast to hydrolysis by gastric acid, most tannins are metabolized by colonic bacteria. Urolithins can be detected in urine approximately one week after ellagitannin consumption, highlighting the critical role of the gut microbiota in their bioavailability. Variations in microbiota composition directly influence urolithin production.

Some subjects did not produce urolithins whereas some subjects had surprisingly high concentrations of ellagic acid. Based on the type of urolithins produced, humans can be stratified into several metabotypes that differ in the composition of the gut microbiota. This substantial interindividual variability in urolithin production is a key limitation when interpreting studies on the health effects of ellagitannin-rich foods and supplements.

For condensed tannins, the composition of these compounds varies based on the constituent flavan-3-ol units, degree of polymerization, and type of interflavan linkage, all of which can affect their bioavailability, metabolism, and physiological effects. Larger oligomers are generally poorly absorbed intact; monomers such as catechin and epicatechin are more bioavailable and can be detected in plasma.

6. Scientific Evidence by Area of Use

6.1 Urinary Tract Infection (UTI) Prevention — Cranberry Proanthocyanidins

The area with the strongest and most clinically relevant human evidence for tannins is the use of A-type proanthocyanidins from cranberry in the prevention of recurrent UTIs.

Cranberry proanthocyanidins, characterized by a series of catechin oligomers with one or more A-type linkages — and therefore structurally quite different from proanthocyanidins from other sources like grape and apple — have been observed to be the only ones able to elicit bacterial anti-adhesion activity in humans. These results have been confirmed by several animal studies, which suggest that cranberry proanthocyanidins and/or their metabolites are able to inhibit bacterial adhesion to uroepithelium.

Proanthocyanidins are under preliminary research for the potential to reduce the risk of urinary tract infections by consuming cranberries, grape seeds, or red wine. In 2019, the American Urological Association released guidelines stating that a moderate level of evidence supports the use of cranberry products containing proanthocyanidins for possible prevention from recurrent UTIs.

A human intervention study reported: in the cranberry group, UTIs were significantly fewer (10.8% vs. 25.8%, p = 0.04). Overall, the evidence is moderate but the mechanistic rationale is well-supported; results are product-specific and dependent on PAC content and the presence of A-type linkages.

6.2 Cardiovascular Health

Tannins exhibit a great number of remarkable pharmacological activities including cardioprotective effects. Tannins have been systematically studied for their beneficial effects on different types of cardiovascular disorders. Preclinical studies have been conducted on both hydrolyzable and condensed tannins to investigate the molecular mechanisms underlying their effects in various cardiovascular disorders such as hypertension, arrhythmia, congestive heart failure, myocardial infarction, and coronary heart disease. Condensed tannins have been studied clinically to prove their beneficial effects against various cardiovascular diseases.

Proanthocyanidins are the principal polyphenols in red wine that are under research to assess risk of coronary heart disease and lower overall mortality. However, evidence from red wine is confounded by the presence of other active compounds including resveratrol and alcohol itself. In pomegranate-specific RCT meta-analyses, a systematic review and meta-analysis of patients with type 2 diabetes (7 randomized controlled trials, N=350) reported no significant changes in lipid parameters (total cholesterol, triglycerides, LDL, HDL) with pomegranate supplementation at various dosages and durations of 6 to 12 weeks. Similar results were reported in another meta-analysis of 12 randomized controlled trials (N=545) enrolling both healthy subjects and subjects with various conditions consuming pomegranate preparations at various dosages and durations of 10 days to 1 year. Overall, the cardiovascular evidence base for tannin-rich preparations in humans is mixed, with stronger preclinical than clinical support. The evidence is preliminary for most tannin-specific cardiovascular endpoints.

6.3 Antidiabetic and Metabolic Effects

Plant tannins are polyphenolic substances with various molecular weights and variable complexity. Due to the beneficial effects for controlling chronic disorders, particularly diabetes mellitus, this class of secondary metabolites has gained increasing interest in recent years.

A review aimed to collect, analyze, and discuss all available information related to the antidiabetic effect of isolated tannins (including both condensed and hydrolyzable varieties) and tannin-rich plants. The bibliographic research gathered more than 41 medicinal plants containing tannins and 19 isolated tannins and tannin-rich crude extracts revealed to possess glucose-lowering effects according to pharmacological studies. Mechanisms include inhibition of α-amylase and α-glucosidase (slowing carbohydrate digestion) and insulin sensitization pathways. Studies with cinnamon, which contains uniquely linked proanthocyanidins, support a role for improved glucose metabolism in type 2 diabetics. Most of the evidence is, however, from in vitro and animal models; large-scale, long-term human RCTs are lacking.

6.4 Antioxidant Effects in Humans

There is human biomarker-level evidence that tannin-rich supplements modulate oxidative stress markers. A study found that tannin extracts improved cardiovascular, metabolic, and hepatic function, suggesting that ellagitannins from oak bark may enhance the beneficial effects of red wine. A preliminary human study with pomegranate dietary supplement capsules over 28 days reported preliminary evidence of a reduction in thiobarbituric acid reactive substances (TBARS) in subjects; no adverse events related to the dietary supplement consumption or changes in hematology, serum chemistry, or urinalyses were observed, and no allergic reactions were observed in any of the 79 subjects who consumed the dietary supplement, demonstrating the safety of a pomegranate ellagitannin-enriched supplement and suggesting a demonstrable antioxidant effect in humans.

6.5 Renal Function — Proanthocyanidins

A cohort study was performed to determine the association of habitual proanthocyanidin intake with renal function and risk of clinical renal outcomes in a population of elderly Caucasian women. Compared to participants with low consumption, participants in the highest tertile of proanthocyanidin intake had a 9% lower cystatin C concentration (p < 0.001). High proanthocyanidin consumers were at 50% lower risk of moderate chronic kidney insufficiency, and 65% lower risk of experiencing a 5-year renal disease event (p < 0.05). Proanthocyanidin intake was associated with improved renal function and reduced risk of chronic kidney disease and renal disease–associated events. This is observational data and does not establish causality; it is not confirmed by interventional trials.

6.6 Antimicrobial and Anti-Biofilm Effects

The antimicrobial activity has been demonstrated for many tannins extracted from plants. Tannin-rich plant extracts have shown high antimicrobial effects. Penta-O-galloyl-β-D-glucose, either in solution or coated on solid surfaces, was shown to be able to inhibit biofilm formation by Staphylococcus aureus by inhibiting bacterial attachment and formation of polysaccharide intercellular adhesin. These data are predominantly in vitro. Human clinical trials specifically assessing tannins as antimicrobial agents remain limited in number and scope.

6.7 Anti-Inflammatory and Wound Healing

The anti-inflammatory effects of tannic acid have been studied in a formalin-induced paw edema model. The edema inhibition rate in the tannic acid group was similar to that in the indomethacin-applied group, suggesting that tannic acid can inhibit edema by decreasing MPO enzyme activity; however, the molecular mechanism remains unclear. Witch hazel bark preparations, rich in condensed tannins and hamamelitannin, have received EU regulatory recognition for topical anti-inflammatory use. Evidence remains largely preclinical with some traditional and observational clinical support.

6.8 Hemostasis

Tannins have been studied for their role in modulating hemostasis. Their protein-precipitating action and vasoconstriction-promoting astringency underpins traditional wound-sealing applications. Tannic acid has been investigated in surgical contexts for stabilizing cardiac implant materials; however, this body of work is primarily preclinical and materials science-oriented rather than dietary supplementation-focused.

6.9 Skin and Pigmentation

Grape seed proanthocyanidins and cranberry proanthocyanidins with vitamins A, C, and E improved chloasma (melasma) in an intervention study. This represents a small intervention study finding; further confirmatory trials are needed.

6.10 Gut Microbiota and Systemic Health via Urolithins

The bioconversion of ellagitannins by gut microbiota into bioavailable urolithins is associated with significant health benefits, including anti-inflammatory, anticancer, antiglycative, antioxidant, and antimicrobial effects observed in vitro. The consumption of ellagitannins has often been associated with positive effects on many pathologies, including cardiovascular diseases, neurodegenerative syndromes, and cancer. Although multiple biological activities have been discussed for ellagitannins, their limited bioavailability prevents reaching significant concentrations in systemic circulation. Instead, urolithins — ellagitannin gut microbiota-derived metabolites — are better absorbed and could be the bioactive molecules responsible for the antioxidant and anti-inflammatory activities or anti-tumor cell progression. The clinical evidence for urolithin-specific benefits in humans is still emerging; most evidence is in vitro or from early-phase human bioavailability studies.

6.11 Cancer — Preliminary and Preclinical Evidence Only

Proanthocyanidins, compounds highly concentrated in dietary fruits such as cranberries and grapes, demonstrate significant cancer prevention potential against many types of cancer. An interest has developed in proanthocyanidins for their chemopreventive and chemotherapeutic potential in many stages of oral carcinogenesis. Proanthocyanidins are polyphenolic compounds derived from common dietary foods such as grapes, cranberries, and almonds, as well as chocolate and cacao beans. Recent evidence suggests that proanthocyanidins may exhibit cytotoxicity against some cancers, including colon, breast, and prostate cancers. This evidence is predominantly in vitro and animal-model based; no human clinical trials have established tannins or their fractions as anticancer treatments.

7. Body Systems and Health Areas of Association

Known for their antioxidant, anti-inflammatory, and cardioprotective properties, tannins also have therapeutic applications including metal chelation, the promotion of vascular health, and disease prevention. The following body systems have the most documented research associations:

• Gastrointestinal system: Antidiarrheal, astringent, gastroprotective, and antimicrobial roles in the gut; modulation of gut microbiota composition; transformation of ellagitannins into urolithins.
• Cardiovascular system: Inhibition of LDL oxidation, vasodilation via nitric oxide, platelet aggregation modulation, blood pressure effects — primarily in preclinical and epidemiological data.
• Metabolic system: Inhibition of carbohydrate-digesting enzymes, insulin sensitization, blood glucose modulation — evidence largely from in vitro and animal studies with some human data.
• Urinary system: Anti-adhesion of uropathogenic bacteria (A-type cranberry PACs); moderate clinical evidence for recurrent UTI prevention.
• Integumentary (skin) system: Wound healing, hemostasis, anti-inflammatory topical effects; historically and pharmacopoeially recognized uses.
• Immune system: Antimicrobial, antiviral, anti-biofilm effects; cytokine modulation.
• Nervous system: Polyphenols exhibit a neuroprotective effect because of their pronounced antioxidant and anti-inflammatory activity. Several studies underline the role of the gut microbiota in the metabolism of polyphenols, producing bioactive molecules that are absorbed through the gastrointestinal tract. Evidence is primarily in vitro and animal-model based.

8. Dosage Forms and Doses Reported in Studies

There is no established universal recommended daily intake for tannins as a supplement class. The following dosages are those specifically reported in the cited research:

• Pomegranate juice: A 2018 systematic review of 11 studies concluded that pomegranate juice (6.7 to 16 ounces per day) or pomegranate extract (1,000 mg before exercise) may help improve endurance and strength exercise performance and recovery, especially when administered at least 1 hour before exertion.
• Pomegranate extract (ellagitannin-enriched): A crossover pharmacokinetic study in healthy volunteers used pomegranate extracts providing either 130 mg punicalagin + 524 mg ellagic acid (PE-1) or 279 mg punicalagin + 25 mg ellagic acid (PE-2).
• Pomegranate extract (general safety study): A study demonstrated in preliminary fashion that a pomegranate extract dietary supplement is safe when ingested by healthy human subjects in amounts of 2 pomegranate capsules per day for 28 days.
• Condensed tannin (grape seed extract, iron bioavailability study): A dose-response clinical trial used 0.03 g, 0.25 g, and 1.5 g of 95% condensed proanthocyanidins from grape seed extract, consumed three times daily for 4 weeks each, in a randomized crossover design.
• Condensed tannin (iron status in premenopausal women): Delimont and colleagues found that 4 weeks of condensed tannin supplementation (1.5, 0.35, and 0.03 g, three times per day) had no impact on iron bioavailability or status in premenopausal women.
• Proanthocyanidin-rich grape seed extract (animal bioavailability): Rats were given GSE orally at 300 mg/kg, twice a day, and blood and urine were collected over a 24-hour period — this is a preclinical dose and not directly translatable to humans.

While proanthocyanidins are widely used as dietary supplements, more evidence is needed to confirm their safety and to assess potential long-term toxicity.

9. Safety Considerations and Interactions

9.1 Antinutritional Effects on Mineral Absorption

Under certain pH and temperature conditions, tannins can form complexes with essential nutrients, such as proteins, carbohydrates, and certain minerals, inhibiting their absorption. It is accepted that tannins reduce iron availability before absorption through the formation of insoluble antinutritional-mineral complexes.

The clinical significance of this effect depends critically on timing: tea, one of the richest sources of dietary tannins, may inhibit iron absorption when consumed directly with a nonheme iron-rich meal. In a study of healthy adults, iron absorption was decreased by 37% when tea was consumed with an iron-fortified porridge; however, it was not affected when tea was consumed an hour after the meal.

Long-term supplementation does not necessarily impair iron status: Delimont and colleagues found that 4 weeks of condensed tannin supplementation (1.5, 0.35, and 0.03 g, three times per day) had no impact on iron bioavailability or status in premenopausal women. However, excessive consumption of tannins from legumes has not been associated with toxicity in humans.

Several mechanisms have been proposed in animal toxicity studies: (i) inhibition of substrates and microbial enzymes that limit microbial growth through tannin–protein interactions; (ii) effects on cell membranes, such as the inhibition of oxidative phosphorylation and the electron transport chain; and (iii) the chelation of essential ions such as iron and zinc.

9.2 Protein and Digestive Enzyme Binding

Studies of legumes show that tannin–protein complexes reduce protein digestibility, decrease amino acid availability, and increase fecal nitrogen in animals. This effect is relevant at high dietary tannin loads (e.g., high-tannin sorghum as a dietary staple) but is less certain at typical supplemental doses. Condensed tannins can inhibit a number of digestive enzymes, including α-amylase, α-glycosidase, pepsin, trypsin, lipase, and chymotrypsin, which may reduce macronutrient availability if tannins are consumed in large amounts around meals.

9.3 Toxicity Profile

Any toxicity associated with tannins can derive from their complexation with metallic ions, mainly because biological systems require metallic ions as enzymatic cofactors. High-dose tannic acid has demonstrated hepatotoxicity in animal studies, though this has not been replicated at doses obtained from typical dietary or supplemental tannin sources. Excessive consumption of tannins from legumes has not been associated with toxicity in humans.

9.4 Drug Interactions

Iron supplements: Tannin-rich foods and supplements should not be taken simultaneously with iron supplements, as the formation of insoluble tannin–iron complexes significantly reduces the absorption of supplemental non-heme iron. Separating administration by at least one hour mitigates this effect, as shown by the tea–porridge timing study cited above.

Anticoagulants: Tannin-rich botanical preparations, particularly those derived from pomegranate peel, have demonstrated pharmacodynamic and pharmacokinetic interactions with warfarin in preclinical models. Significant reduction in CYP2C8, 2C9, and 3A4 was seen upon concomitant use of warfarin with ellagic acid. All combinations enhanced the anticoagulant activity of warfarin; the investigation confirmed serious drug–herb interactions between warfarin and pomegranate peel or guava leaf extracts. Such results might indicate a high risk of bleeding from the co-administration of these herbal drugs with warfarin therapy. These are animal (rat) pharmacokinetic data and require confirmation in humans, but they signal a pharmacologically plausible interaction warranting caution.

Other medications: Given that tannins bind proteins and can inhibit CYP enzymes, co-administration of tannin-rich supplements with medications that have narrow therapeutic windows or that are extensively metabolized by CYP2C9 and CYP3A4 requires caution. Synergistic effects of polyphenols with antidiabetic drugs have been documented, but also antagonistic interactions that may impair drug efficacy. Therefore, additional research is required to clarify mutual interactions in order to use the knowledge in clinical applications.

9.5 Product Quality and Standardization Concerns

The content of ellagic acid has been used to standardize most pomegranate extract dietary supplements marketed. However, supplements can be adulterated with ellagic acid from less expensive plant sources, undercutting this method of standardization. To compare the phytochemical contents and antioxidant activities of commercially available pomegranate extract dietary supplements, a total of 27 different supplements in the form of capsules, tablets, and soft gels were studied. This investigation revealed significant variability in the actual content of key tannin constituents (such as punicalagins) among commercial products, indicating that label claims may not reliably reflect the actual bioactive tannin content.

9.6 Pycnogenol® (Pine Bark Proanthocyanidins)

Proanthocyanidins found in the proprietary extract of maritime pine bark called Pycnogenol were not found (as of 2012) to be effective as a treatment for any disease: "Current evidence is insufficient to support Pycnogenol® use for the treatment of any chronic disorder." This regulatory assessment underscores the gap between in vitro/animal data and confirmed clinical efficacy across tannin-based supplement products generally.

10. Summary of Evidence Strength by Application

• UTI prevention (cranberry A-type PACs): Moderate clinical evidence; supported by a guideline statement from the American Urological Association (2019).
• Antioxidant biomarker modulation: Modest human evidence from short-term intervention studies; clinical significance uncertain.
• Topical astringent/wound healing (witch hazel, tannic acid): Pharmacopoeial and traditional recognition; limited formal RCT data in humans.
• Antidiabetic/hypoglycemic: Preclinical and mechanistic evidence is strong; human clinical trial data are limited and inconsistent.
• Cardiovascular (lipid, blood pressure): Mixed results in human meta-analyses; no clear consensus effect for tannin-rich supplements on major lipid parameters in RCTs.
• Antimicrobial: Strong in vitro evidence; human clinical trial data are sparse.
• Anticancer: Exclusively in vitro and animal model evidence; no human clinical benefit established.
• Neuroprotection: Preliminary; largely in vitro and animal-model based.

References

• Fraga-Corral M, et al. Traditional Applications of Tannin Rich Extracts Supported by Scientific Data: Chemical Composition, Bioavailability and Bioaccessibility. Foods. 2021;10(2):251. PMC7912241.
• Comprehensive Review of Bioactive Tannins in Foods and Beverages: Functional Properties, Health Benefits, and Sensory Qualities. PMC. PMC11858154.
• Smeriglio A, et al. Proanthocyanidins and hydrolysable tannins: occurrence, dietary intake and pharmacological effects. British Journal of Pharmacology. 2017;174(11). PubMed 27646690.
• Antioxidant and Health-Related Effects of Tannins: From Agri-Food By-Products to Human and Animal Health. PMC. PMC12837330.
• Huang Q, et al. Potential and challenges of tannins as an alternative to in-feed antibiotics for farm animal production. Animal Nutrition. 2018;4(2):137-150. PMC6104569.
• Kozlowska A, Szostak-Wegierek D. Tannic Acid with Antiviral and Antibacterial Activity as A Promising Component of Biomaterials—A Minireview. Materials. 2020;13(14):3224. PMC7412100.
• Biological Function of Plant Tannin and Its Application in Animal Health. Frontiers in Veterinary Science. PMC8784788.
• Espín JC, et al. Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So Far. Evidence-Based Complementary and Alternative Medicine. 2013. PMC3679724.
• The Impact of Ellagitannins and Their Metabolites through Gut Microbiome on the Gut Health and Brain Wellness within the Gut–Brain Axis. PMC. PMC9858309.
• Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota. PMC. PMC9787965.
• Tannins as Hemostasis Modulators. Frontiers in Pharmacology. PMC8793672.
• Petroski W, Minich DM. Is There Such a Thing as "Anti-Nutrients"? A Narrative Review of Perceived Problematic Plant Compounds. Nutrients. 2020;12(10):2929. PMC7600777.
• Delimont NM, et al. Long-Term Dose-Response Condensed Tannin Supplementation Does Not Affect Iron Status or Bioavailability. Current Developments in Nutrition. 2018. PMC5998780.
• The Diverse Efficacy of Food-Derived Proanthocyanidins for Middle-Aged and Elderly Women. PMC. PMC7765374.
• Tannin profile, antioxidant properties, and antimicrobial activity of extracts from two Mediterranean species of parasitic plant Cytinus. PMC. PMC6451225.
• Evaluating Tannins and Flavonoids from Traditionally Used Medicinal Plants with Biofilm Inhibitory Effects against MRGN E. coli. PMC. PMC9000218.
• Possible Side Effects of Polyphenols and Their Interactions with Medicines. PMC. PMC10058246.
• Critical pharmacokinetic and pharmacodynamic drug-herb interactions in rats between warfarin and pomegranate peel or guava leaves extracts. PMC. PMC6344987.
• Belmejdoub G, et al. The Promising Role of Plant Tannins as Bioactive Antidiabetic Agents. Current Pharmaceutical Design. 2018. PubMed 29874989.
• Pharmacological effects and mechanisms of tannic acid. Biomedicine & Pharmacotherapy. 2022.
• USDA Forest Service. Tannins — Ethnobotany.
• Liquid chromatography tandem mass spectrometry identification of proanthocyanidins in rat plasma after oral administration of grape seed extract. PMC. PMC4995451.
• Proanthocyanidins: A comprehensive review. Biomedicine & Pharmacotherapy. 2019.
• Cranberry and Grape Seed Extracts Inhibit the Proliferative Phenotype of Oral Squamous Cell Carcinomas. PMC. PMC3138501.
• Seeram NP, et al. Absence of Pomegranate Ellagitannins in the Majority of Commercial Pomegranate Extracts: Implications for Standardization and Quality Control. Journal of Agricultural and Food Chemistry. 2009.
• Tannin in foods: Classification, Dietary Sources, and Processing Strategies to Minimize Anti-Nutrient Effects. Food and Bioprocess Technology. 2025.
• Dietary Supplementation of Tannins: Effect on Growth Performance, Serum Antioxidant Capacity, and Immunoglobins of Weaned Piglets—A Systematic Review with Meta-Analysis. PMC. PMC10886058.
• ClinicalTrials.gov. Multiple Daily Condensed Tannin Supplementation and Iron Bioavailability: The Tannin Dose Response Trial. NCT03030716.
• Ellagic Acid and Gut Microbiota: Interactions, and Implications for Health. PMC. PMC11972986.
• Proanthocyanidin — Wikipedia (as a pointer to cited guideline references only).